The financing round was led by Socii Capital with backing from Autodesk, Saint-Gobain and other investors.
"We have been fortunate to work with global industry leaders who share our vision for innovative construction methods and a productised supply chain. This latest fundraising gives us further confidence that KOPE will support those in our industry looking to adopt prefabrication and offsite manufacturing. With these key industry partners and their broad experience, we are excited about this next phase of our journey."
The fintech company has raised £2m from existing backers Thomson Reuters Ventures and Love Ventures to accelerate product development and commercial growth.
"We’re reinvesting in Detected because we have a strong belief in the company’s long-term potential. As customers, we have seen first-hand the impact the technology has, and we’re excited about the momentum that Detected has developed in the market."
Octopus Ventures led the seed financing, with participation from Horizons Ventures, Verve Ventures, and Air Street Capital, to commercialise live cell imaging technology.
"University spin-outs like CellVoyant are at the heart of the UK’s thriving biotech ecosystem. CellVoyant sets a new standard in precision and reliability for predicting and controlling stem cell behaviour, which will make cell therapies more accessible to those who need them. We are thrilled to invest into a company that is transforming how patients can benefit from life-changing treatments."
